National Database of Bone Metastases

Recruiting Observational Study
Bone Metastases
No Placebo Group Every participant receives an active treatment — no one gets a placebo. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Observational
Participants needed
800 (estimated)
Sponsor
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

BDMO is an Italian multicentre, observational, prospective study that collects data from all patients with bone metastases referred to each participating centre, using an on-line software 'tailor-made' for data collection.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Radiological and/or histological diagnosis of bone metastasis from histologically established solid tumor * Males or females aged \>= 18 years * Informed consent Exclusion Criteria: * Not applicable
Contacts

Nicoletta Ranallo, MD

nicoletta.ranallo@irst.emr.it

CONTACT

Centro di Coordinamento

cc.ubsc@irst.emr.it

CONTACT